Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 638.80
+15.00 (2.40%)
Sep 2, 2025, 10:52 AM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 140.46 billion as of August 29, 2025. Its market cap has decreased by -32.10% in one year.
Market Cap
140.46B
Enterprise Value
163.95B
Revenue
27.87B
Ranking
n/a
PE Ratio
34.51
Stock Price
638.80
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 140.46B, an increase of 2,288.76%. That is a compound annual growth rate of 12.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 140.46B | -20.65% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | 197.71B | 12.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,594.30B |
| Genmab | 97.67B |
| Demant | 51.98B |
| ALK-Abelló | 45.26B |
| H. Lundbeck | 38.60B |
| Zealand Pharma | 31.63B |
| Ambu A/S | 25.64B |
| Bavarian Nordic | 18.42B |